En este asunto

MEDICAL DEVICES RULES, 2017 OPENS UP ENORMOUS OPPORTUNITIES

The new Medical Devices Rules, 2017 seek to remove regulatory bottlenecks to make in India, facilitate ease of doing business while ensuring availability of better medical devices for patient care and safety. The rules will also regulate a much larger set of medical devices under a framework customized for medical devices. The stakeholders are hoping that the system will be industry friendly and will indeed create an ecosystem that will enable to boost medical technology innovation and manufacturing in the country.

Temasek Acquires Rs 1000 Cr Stake In Manipal Hospitals

Singapore’s Temasek Holding has agreed to acquire a Rs 1,000-crore stake in Manipal Hospitals in a deal that possibly turns the Bengaluru-based private healthcare network into an industry consolidator.

1 min

Natco Pharma Plans API Expansion With More Investment

Hyderabad-based Natco Pharma is planning to expand its Active Pharmaceutical Ingredient (API) and intermediates manufacturing facility in Tamil Nadu. The company is looking at investing in its existing facility, in Thiruvallur District.

1 min

Medical Devices Rules, 2017 Opens Up Enormous Opportunities

The new Medical Devices Rules, 2017 seek to remove regulatory bottlenecks to make in India, facilitate ease of doing business while ensuring availability of better medical devices for patient care and safety. The rules will also regulate a much larger set of medical devices under a framework customized for medical devices. The stakeholders are hoping that the system will be industry friendly and will indeed create an ecosystem that will enable to boost medical technology innovation and manufacturing in the country.

10 mins

Association Of Indian Medical Device Industry (AIMED) Recommendations

Association Of Indian Medical Device Industry (AIMED) Recommendations

2 mins

Make In India' - A Major Boon To Medical Technology Industry

Having a solid expertise in research and development, Trivitron manufactures and distributes exceptional medical technology products to 165 countries for the last 20 years. Today, Trivitron Healthcare, through successful inorganic synergies with local and global firms, has a revenue turnover of Rs 750 crore. BioSpectrum India spoke to Dr GSK Velu, Chairman & Managing Director, Trivitron Healthcare Group of Companies to about the status of medical technology market in India and competition coming from Chinese medical devices.Excerpts of the interview

4 mins

China's Maiden Billion-Dollar Takeover Of An Indian Pharma Giant

The deal will help the Chinese company make inroads into India, gain access to US injectable drug market where Gland has a firm hold and bolster its product portfolio.

6 mins

“Private Sector, Government Need To Work Together To Make Healthcare Accessible In Rural India”

For the first time National Heath Policy is talking about the preventive healthcare and wellness. From the statement point of view, it is really a commendable thing but now it has to be translated on to the ground. Harish Pillai COO, Indus Health Plus in an interaction with BioSpectrum India talks about why preventive healthcare is the need of the hour and how it can be successful.

5 mins

IP In Start-Up Ecosystem

In this age of innovation and technology, Intellectual Property (IP) is an essential element for an organization to sustain and flourish over long periods of time. This is particularly applicable for organizations which rely heavily on R&D to develop technology based solutions for existing problems, and the biotech startup community is no different.

4 mins

Leer todas las historias de Bio Spectrum

Bio Spectrum Magazine Description:

India's leading publication that covers the business of bio-technology. With comprehensive analyses of policy issues, products and services across the bio-pharma, bio-informatics, bio-infrastructure and bio-agriculture segments, it is the industry's most authoritative source of information.